Benjamin L. Palleiko, CEO of KalVista Pharmaceuticals ($KALV), sold shares on the open market 15 times over the past year, totaling about $1.8 million. His most recent sale occurred on March 9, 2026. These sales rank him 3,693rd among 11,678 insiders in our database by total value sold, below the average of $8.6 million across about 6 transactions per insider. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 6, 2026 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 15625 | $0.00 | 458,508.0000 | 53,883,681 | 3.53% | 0.03% |
| March 6, 2026 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 15625 | $0.00 | 125,001.0000 | 53,883,681 | 11.11% | 0.03% |
| March 9, 2026 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 6693 | $16.08 | 451,815.0000 | 53,883,681 | 1.46% | 0.01% |
| Feb. 21, 2026 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 23250 | $0.00 | 279,000.0000 | 53,883,681 | 7.69% | 0.04% |
| Feb. 23, 2026 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 10034 | $15.57 | 442,883.0000 | 53,883,681 | 2.22% | 0.02% |
| Feb. 21, 2026 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 23250 | $0.00 | 452,917.0000 | 53,883,681 | 5.41% | 0.04% |
| Feb. 18, 2026 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 1038 | $15.00 | 429,667.0000 | 53,883,681 | 0.24% | 0.00% |
| Feb. 17, 2026 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 2419 | $0.00 | 430,705.0000 | 53,883,681 | 0.56% | 0.00% |
| Feb. 17, 2026 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 2419 | $0.00 | 2,419.0000 | 53,883,681 | 50.00% | 0.00% |
| Feb. 12, 2026 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 3354 | $15.70 | 428,286.0000 | 53,883,681 | 0.78% | 0.01% |
| Feb. 11, 2026 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 7120 | $0.00 | 99,680.0000 | 53,883,681 | 6.67% | 0.01% |
| Feb. 11, 2026 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 7120 | $0.00 | 431,640.0000 | 53,883,681 | 1.68% | 0.01% |
| Jan. 16, 2026 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | A | Restricted Stock Unit | 325000 | $0.00 | 325,000.0000 | 53,883,681 | 9999.99% | 0.60% |
| Dec. 6, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 15625 | $0.00 | 431,814.0000 | 53,883,681 | 3.75% | 0.03% |
| Dec. 6, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 15625 | $0.00 | 140,626.0000 | 53,883,681 | 10.00% | 0.03% |
| Dec. 8, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 7294 | $16.51 | 424,520.0000 | 53,883,681 | 1.69% | 0.01% |
| Nov. 24, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 10940 | $13.45 | 416,189.0000 | 53,883,681 | 2.56% | 0.02% |
| Nov. 21, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 23250 | $0.00 | 427,129.0000 | 53,883,681 | 5.76% | 0.04% |
| Nov. 21, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 23250 | $0.00 | 302,250.0000 | 53,883,681 | 7.14% | 0.04% |
| Nov. 17, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 6945 | $0.00 | 0.0000 | 53,883,681 | 100.00% | 0.01% |
| Nov. 18, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 4466 | $14.48 | 403,879.0000 | 53,883,681 | 1.09% | 0.01% |
| Nov. 17, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 9364 | $0.00 | 408,345.0000 | 53,883,681 | 2.35% | 0.02% |
| Nov. 17, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 2419 | $0.00 | 4,838.0000 | 53,883,681 | 33.33% | 0.00% |
| Nov. 11, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 7120 | $0.00 | 402,309.0000 | 53,883,681 | 1.80% | 0.01% |
| Nov. 12, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 3328 | $11.55 | 398,981.0000 | 53,883,681 | 0.83% | 0.01% |
| Nov. 11, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 7120 | $0.00 | 106,800.0000 | 53,883,681 | 6.25% | 0.01% |
| Sept. 6, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 15625 | $0.00 | 402,483.0000 | 49,652,878 | 4.04% | 0.03% |
| Sept. 6, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 15625 | $0.00 | 156,251.0000 | 49,652,878 | 9.09% | 0.03% |
| Sept. 8, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 7294 | $15.84 | 395,189.0000 | 49,652,878 | 1.81% | 0.01% |
| Aug. 21, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 23250 | $0.00 | 397,798.0000 | 49,652,878 | 6.21% | 0.05% |
| Aug. 21, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 23250 | $0.00 | 325,500.0000 | 49,652,878 | 6.67% | 0.05% |
| Aug. 22, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 10940 | $13.22 | 386,858.0000 | 49,652,878 | 2.75% | 0.02% |
| Aug. 17, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 2418 | $0.00 | 7,257.0000 | 49,652,878 | 24.99% | 0.00% |
| Aug. 17, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 6944 | $0.00 | 6,945.0000 | 49,652,878 | 50.00% | 0.01% |
| Aug. 18, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 4409 | $13.19 | 374,548.0000 | 49,652,878 | 1.16% | 0.01% |
| Aug. 17, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 9362 | $0.00 | 378,957.0000 | 49,652,878 | 2.53% | 0.02% |
| Aug. 11, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | A | Restricted Stock Unit | 113920 | $0.00 | 113,920.0000 | 49,652,878 | 9999.99% | 0.23% |
| Aug. 11, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | A | Employee Stock Option | 113920 | $0.00 | 113,920.0000 | 49,652,878 | 9999.99% | 0.23% |
| July 9, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 32979 | $15.69 | 369,595.0000 | 49,652,878 | 8.19% | 0.07% |
| July 8, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | A | Common Stock | 87500 | $0.00 | 402,574.0000 | 49,652,878 | 27.77% | 0.18% |
| June 9, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 7169 | $14.50 | 315,074.0000 | 49,652,878 | 2.22% | 0.01% |
| June 6, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 15625 | $0.00 | 322,243.0000 | 49,652,878 | 5.10% | 0.03% |
| June 6, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 15625 | $0.00 | 171,876.0000 | 49,652,878 | 8.33% | 0.03% |
| May 22, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 9999 | $11.88 | 306,618.0000 | 49,652,878 | 3.16% | 0.02% |
| May 21, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 23250 | $0.00 | 316,617.0000 | 49,652,878 | 7.93% | 0.05% |
| May 21, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 23250 | $0.00 | 348,750.0000 | 49,652,878 | 6.25% | 0.05% |
| May 17, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 2419 | $0.00 | 9,675.0000 | 49,652,878 | 20.00% | 0.00% |
| May 17, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 6945 | $0.00 | 13,889.0000 | 49,652,878 | 33.33% | 0.01% |
| May 17, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 9364 | $0.00 | 297,175.0000 | 49,652,878 | 3.25% | 0.02% |
| May 19, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 3808 | $11.84 | 293,367.0000 | 49,652,878 | 1.28% | 0.01% |
| March 6, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 15625 | $0.00 | 294,480.0000 | 46,590,154 | 5.60% | 0.03% |
| March 7, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 6669 | $11.97 | 287,811.0000 | 46,590,154 | 2.26% | 0.01% |
| March 6, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 15625 | $0.00 | 187,501.0000 | 46,590,154 | 7.69% | 0.03% |
| Feb. 21, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | A | Restricted Stock Unit | 372000 | $0.00 | 372,000.0000 | 46,590,154 | 9999.99% | 0.80% |
| Feb. 17, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 6944 | $0.00 | 20,834.0000 | 46,590,154 | 25.00% | 0.01% |
| Feb. 17, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 9363 | $0.00 | 283,959.0000 | 46,590,154 | 3.41% | 0.02% |
| Feb. 17, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 2419 | $0.00 | 12,094.0000 | 46,590,154 | 16.67% | 0.01% |
| Feb. 18, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 5104 | $9.82 | 278,855.0000 | 46,590,154 | 1.80% | 0.01% |
| Dec. 6, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 15625 | $0.00 | 282,223.0000 | 46,590,154 | 5.86% | 0.03% |
| Dec. 6, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 15625 | $0.00 | 203,126.0000 | 46,590,154 | 7.14% | 0.03% |
| Dec. 9, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 7627 | $9.75 | 274,596.0000 | 46,590,154 | 2.70% | 0.02% |
| Nov. 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Performance Stock Units | 20834 | $0.00 | 0.0000 | 46,590,154 | 100.00% | 0.04% |
| Nov. 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 30198 | $0.00 | 280,998.0000 | 46,590,154 | 12.04% | 0.06% |
| Nov. 18, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 14400 | $9.26 | 266,598.0000 | 46,590,154 | 5.12% | 0.03% |
| Nov. 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 2419 | $0.00 | 14,513.0000 | 46,590,154 | 14.29% | 0.01% |
| Nov. 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 6945 | $0.00 | 27,778.0000 | 46,590,154 | 20.00% | 0.01% |
| Sept. 9, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 7352 | $12.19 | 250,800.0000 | 36,786,575 | 2.85% | 0.02% |
| Sept. 6, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 15625 | $0.00 | 258,152.0000 | 36,786,575 | 6.44% | 0.04% |
| Sept. 6, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 15625 | $0.00 | 218,751.0000 | 36,786,575 | 6.67% | 0.04% |
| Aug. 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 6944 | $0.00 | 34,723.0000 | 36,786,575 | 16.67% | 0.02% |
| Aug. 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 30195 | $0.00 | 256,742.0000 | 36,786,575 | 13.33% | 0.08% |
| Aug. 19, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 14215 | $12.01 | 242,527.0000 | 36,786,575 | 5.54% | 0.04% |
| Aug. 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 2418 | $0.00 | 16,932.0000 | 36,786,575 | 12.50% | 0.01% |
| Aug. 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Performance Stock Units | 20833 | $0.00 | 20,834.0000 | 36,786,575 | 50.00% | 0.06% |
| June 7, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 7465 | $11.53 | 224,547.0000 | 36,786,575 | 3.22% | 0.02% |
| June 6, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 15625 | $0.00 | 232,012.0000 | 36,786,575 | 7.22% | 0.04% |
| June 6, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 15625 | $0.00 | 234,375.0000 | 36,786,575 | 6.25% | 0.04% |
| May 20, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 21959 | $11.76 | 216,387.0000 | 36,786,575 | 9.21% | 0.06% |
| May 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 6945 | $0.00 | 41,667.0000 | 36,786,575 | 14.29% | 0.02% |
| May 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Performance Stock Units | 20834 | $0.00 | 0.0000 | 36,786,575 | 100.00% | 0.06% |
| May 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 2419 | $0.00 | 19,350.0000 | 36,786,575 | 11.11% | 0.01% |
| May 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Performance Stock Units | 20833 | $0.00 | 41,667.0000 | 36,786,575 | 33.33% | 0.06% |
| May 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 51031 | $0.00 | 238,346.0000 | 36,786,575 | 27.24% | 0.14% |
| March 6, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | A | Restricted Stock Unit | 250000 | $0.00 | 250,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CFO, CBO | M | Restricted Stock Unit | 6944 | $0.00 | 48,612.0000 | 0 | 12.50% | 0.00% |
| Feb. 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CFO, CBO | M | Performance Stock Units | 20833 | $0.00 | 62,500.0000 | 0 | 25.00% | 0.00% |
| Feb. 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CFO, CBO | M | Performance Stock Units | 20833 | $0.00 | 20,834.0000 | 0 | 50.00% | 0.00% |
| Feb. 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CFO, CBO | M | Common Stock | 51029 | $0.00 | 210,117.0000 | 0 | 32.08% | 0.00% |
| Feb. 20, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CFO, CBO | S | Common Stock | 22802 | $14.11 | 187,315.0000 | 0 | 10.85% | 0.00% |
| Feb. 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CFO, CBO | M | Restricted Stock Unit | 2419 | $0.00 | 21,769.0000 | 0 | 10.00% | 0.00% |
| Feb. 14, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CFO, CBO | S | Common Stock | 40855 | $15.01 | 159,088.0000 | 0 | 20.43% | 0.00% |
| Feb. 11, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CFO, CBO | A | Common Stock | 87500 | $0.00 | 199,943.0000 | 0 | 77.82% | 0.00% |
| Feb. 11, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | CFO, CBO | A | Performance Stock Units | 83333 | $0.00 | 83,333.0000 | 0 | 9999.99% | 0.00% |
| Nov. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | President, CFO, CBO & Sec'y | M | Common Stock | 30197 | $0.00 | 125,451.0000 | 0 | 31.70% | 0.00% |
| Nov. 20, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | President, CFO, CBO & Sec'y | S | Common Stock | 13008 | $8.23 | 112,443.0000 | 0 | 10.37% | 0.00% |
| Nov. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | President, CFO, CBO & Sec'y | M | Restricted Stock Unit | 6945 | $0.00 | 55,556.0000 | 0 | 11.11% | 0.00% |
| Nov. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | President, CFO, CBO & Sec'y | M | Restricted Stock Unit | 2419 | $0.00 | 24,188.0000 | 0 | 9.09% | 0.00% |
| Nov. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | President, CFO, CBO & Sec'y | M | Performance Stock Unit | 20833 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | President, CFO, CBO & Sec'y | M | Common Stock | 30195 | $0.00 | 108,321.0000 | 0 | 38.65% | 0.00% |
| Aug. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | President, CFO, CBO & Sec'y | M | Restricted Stock Unit | 6944 | $0.00 | 62,501.0000 | 0 | 10.00% | 0.00% |
| Aug. 18, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | President, CFO, CBO & Sec'y | S | Common Stock | 13067 | $10.73 | 95,254.0000 | 0 | 12.06% | 0.00% |
| Aug. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | President, CFO, CBO & Sec'y | M | Restricted Stock Unit | 2418 | $0.00 | 26,607.0000 | 0 | 8.33% | 0.00% |
| Aug. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | President, CFO, CBO & Sec'y | M | Performance Stock Unit | 20833 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 18, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | President, CFO, CBO & Sec'y | A | Employee Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | President, CFO, CBO & Sec'y | M | Restricted Stock Unit | 6944 | $0.00 | 76,390.0000 | 0 | 8.33% | 0.00% |
| May 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | President, CFO, CBO & Sec'y | M | Restricted Stock Unit | 2419 | $0.00 | 29,025.0000 | 0 | 7.69% | 0.00% |
| May 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | President, CFO, CBO & Sec'y | M | Restricted Stock Unit | 6945 | $0.00 | 69,445.0000 | 0 | 9.09% | 0.00% |
| Jan. 11, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | President, CFO, CBO & Sec'y | A | Restricted Stock Unit | 83334 | $0.00 | 83,334.0000 | 0 | 9999.99% | 0.00% |
| May 18, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | President, CFO, CBO & Sec'y | S | Common Stock | 4037 | $10.14 | 78,126.0000 | 0 | 4.91% | 0.00% |
| May 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | President, CFO, CBO & Sec'y | M | Common Stock | 9364 | $0.00 | 82,163.0000 | 0 | 12.86% | 0.00% |
| Feb. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | President, CFO, CBO & Sec'y | M | Common Stock | 9363 | $0.00 | 77,753.0000 | 0 | 13.69% | 0.00% |
| Feb. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | President, CFO, CBO & Sec'y | S | Common Stock | 4954 | $7.66 | 72,799.0000 | 0 | 6.37% | 0.00% |
| Feb. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | President, CFO, CBO & Sec'y | M | Performance Restricted Stock Unit | 6944 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Palleiko Benjamin L | President, CFO, CBO & Sec'y | M | Restricted Stock Unit | 2419 | $0.00 | 31,444.0000 | 0 | 7.14% | 0.00% |